Quick Bolus - Tandem Mobi Bolus Quick Reference

Quick Bolus

If the Quick Bolus function is turned

on through the Settings menu of the

Tandem Mobi mobile app, a standard

bolus can be delivered by pressing the

Pump button on the pump. Use the

following steps to deliver a quick bolus:

Press and hold the Pump button

Listen for two beeps or feel for vibrations

Press the Pump button for each increment of desired delivery

(e.g., press three times to represent three increments)

Wait for the pump to beep/vibrate for each increment pressed

Press and hold the Pump button until the pump beeps/vibrates to

confirm the bolus delivery

* CGM sold separately.

Important Safety Information: RX ONLY. Indications for Use: Tandem Mobi insulin pump with interoperable technology: The Tandem

Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable

rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate

with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands

from these devices. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use in

individuals 6 years of age and greater. Control‑IQ technology: Control‑IQ technology is intended for use with a compatible iCGM (sold

separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and

predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold.

Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 6 years of age and greater. Control-IQ

technology is intended for single patient use. Control-IQ technology is indicated for use with NovoLog or Humalog U-100 insulin.

WARNING: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in

patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ

technology if using hydroxyurea. Users of a Tandem insulin pump and Control-IQ technology must use the insulin pump, CGM, and

all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by

their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare

provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and

reminders. The Tandem pump and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit

tandemdiabetes.com/safetyinfo for additional important safety information.

registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. ML-1012732_A

(877) 801-6901

tandemdiabetes.com

FOR USE IN THE

UNITED STATES ONLY